BRUSSELS, Nov 19 (Reuters) - EU regulators will ask drug companies for details of deals with makers of generic medicines as part of a crackdown on firms suspected of blocking cheaper treatments, a European Commission official said on Thursday.
European Union Competition Commissioner Neelie Kroes said in her July report into the sector that delays in bringing generic drugs to the market had cost consumers and healthcare providers billions of euros.
.../...
"We will ask companies to give a copy of patent settlements between July 2008 to December 2009," Dominik Schnichels, the head of the Commission's pharma taskforce, told an industry conference on Thursday.
"We will not take the view per se that patent settlements are probably illegal but we would look closely at the justification the company gives for the settlement. We will look at the merits of the case," he said.
Entradas
No hay comentarios:
Publicar un comentario